A new nano-based drug delivery technology could outwit tuberculosis (TB)—one of humanity's most ancient diseases.
Patients with obesity and asthma who used GLP-1 receptor agonists had significantly fewer exacerbations and prednisone use ...
This week, Dr Ray O’Connor takes a look at recent clinical articles on the management of asthma, and what environmental ...
CHICAGO -- A fixed-dose inhaler combining an inhaled corticosteroid, long-acting muscarinic antagonist, and long-acting beta agonist (ICS/LAMA/LABA) improved lung function and reduced exacerbations in ...
When you're preparing your meals in the kitchen, you are probably focused on using the right spices and seasonings. But did you know microplastics are also leaking into your food? microplastics are ...
Intratracheal administration of budesonide mixed with surfactant did not reduce the rates of bronchopulmonary dysplasia (BPD) or death compared with surfactant alone in extremely premature infants by ...
Medical crews immediately boarded the plane and attended to passengers after the forced landing A BRITISH airways flight made an emergency landing in Romania after four people suffered from “smoke ...
AeroRx Therapeutics, Inc., a clinical-stage biopharmaceutical company developing proprietary nebulized combination therapies for chronic respiratory diseases, today announced the closing of a $21 ...
LA JOLLA, Calif., October 07, 2025--(BUSINESS WIRE)--AeroRx Therapeutics, Inc., a clinical-stage biopharmaceutical company developing proprietary nebulized combination therapies for chronic ...
The results show that using a single 2-in-1 anti-inflammatory reliever inhaler – which combines the inhaled corticosteroid (ICS) budesonide and the fast-acting bronchodilator formoterol – reduced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback